| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 764139 | 89271 | RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION | RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 300 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89271/89271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89271/89271_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7687 | AOP ORPHAN PHARMACEUTICALS IBERIA, S.L.U | 2024-02-21 | 1 | 1 | 1 | 2024-02-21 | 2024-02-21 | 1 | 2025-07-15 | View Edit Delete | ||||||||||||
| 764356 | 89367 | BACLOFENO COMBIX 10 MG COMPRIMIDOS EFG | BACLOFENO COMBIX 10 MG COMPRIMIDOS EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89367/89367_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89367/89367_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 0 | 2024-12-09 | View Edit Delete | ||||||||||||
| 764345 | BE215826 | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215826/BE215826_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | MELYFARMA S.L. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 764358 | BE215887 | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/BE215887/BE215887_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28612 | MELYFARMA S.L. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 764329 | 89358 | ARIPIPRAZOL NORMON 30 MG COMPRIMIDOS BUCODISPERSABLES EFG | ARIPIPRAZOL NORMON 30 MG COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89358/89358_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89358/89358_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-04-24 | View Edit Delete | ||||||||||||
| 764334 | 89361 | DESVENLAFAXINA NORMON 100 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG | DESVENLAFAXINA NORMON 100 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89361/89361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89361/89361_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 0 | 2024-09-12 | View Edit Delete | ||||||||||||
| 764335 | 89360 | DESVENLAFAXINA NORMON 50 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG | DESVENLAFAXINA NORMON 50 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89360/89360_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89360/89360_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 0 | 2024-09-12 | View Edit Delete | ||||||||||||
| 764339 | 1000169007 | METALYSE 5.000 UNIDADES (25 MG) POLVO PARA SOLUCION INYECTABLE | METALYSE 5.000 UNIDADES (25 MG) POLVO PARA SOLUCION INYECTABLE, 1 vial | 5.000 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1000169007/1000169007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1000169007/1000169007_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-20 | 2024-02-19 | 1 | 2024-11-06 | View Edit Delete | ||||||||||||
| 669119 | 72113 | FINASTERIDA VIATRIS 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FINASTERIDA VIATRIS 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72113/72113_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72113/72113_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2010-07-27 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-02-20 | View Edit Delete | ||||||||||||
| 697870 | 72113 | FINASTERIDA VIATRIS 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FINASTERIDA VIATRIS 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 98 comprimidos | 1 mg | 5 | 98 | 10 | 98 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72113/72113_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72113/72113_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2010-07-27 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-02-20 | View Edit Delete | ||||||||||||
| 763556 | 89084 | PROLASTINA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN | PROLASTINA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial polvo + 1 vial disolvente de 160 ml + 1 dispositivo de transferencia | 4.000 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente de 160 ml + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89084/89084_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89084/89084_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-09-06 | View Edit Delete | ||||||||||||
| 763559 | 89085 | PROLASTINA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN | PROLASTINA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial polvo + 1 vial disolvente de 200 ml + 1 dispositivo de transferencia | 5.000 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente de 200 ml + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89085/89085_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89085/89085_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 2024-02-19 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-09-06 | View Edit Delete | ||||||||||||
| 764321 | 89352 | REVISEA 80 MG CÁPSULAS BLANDAS | REVISEA 80 MG CÁPSULAS BLANDAS, 30 cápsulas | 80 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89352/89352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89352/89352_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1534 | KERN PHARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764328 | 038983161IP2 | CAPENON 40 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | CAPENON 40 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 28 comprimidos | 40 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/038983161IP2/038983161IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28226 | ELAM PHARMA LABS S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-10-02 | View Edit Delete | ||||||||||||
| 764324 | 89353 | TICAGRELOR NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TICAGRELOR NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 60 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89353/89353_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89353/89353_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 764325 | 89354 | TICAGRELOR NORMON 90 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TICAGRELOR NORMON 90 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 56 comprimidos | 90 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89354/89354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89354/89354_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 764320 | 1231774001 | LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION | LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial con 0,4 ml | 5 mg/ml inyectable 0,4 ml | 45 | 1 | 34 | 1 vial con 0,4 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231774001/1231774001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231774001/1231774001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41362 | IMMEDICA PHARMA AB | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2025-01-14 | View Edit Delete | ||||||||||||
| 766904 | 89357 | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 25 comprimidos | 25 mg | 5 | 25 | 10 | 25 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89357/89357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89357/89357_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2025-02-04 | 1 | 2026-03-26 | View Edit Delete | ||||||||||||
| 766905 | 89357 | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 50 comprimidos | 25 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89357/89357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89357/89357_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2025-02-04 | 1 | 2026-03-26 | View Edit Delete | ||||||||||||
| 764316 | 89346 | EZETIMIBA/ATORVASTATINA STADA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA STADA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 10 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89346/89346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89346/89346_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2024-02-14 | 1 | 1 | 1 | 2024-02-15 | 2024-02-14 | 1 | 2024-12-11 | View Edit Delete |
Page 77 of 1036, showing 20 records out of 20704 total, starting on record 1521, ending on 1540